English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Zynex
Patient Daily
| May 18, 2023
Zynex Announces Proposed $50 Million Offering of Convertible Senior Notes
Patient Daily
| May 18, 2023
Zynex Announces Proposed Secondary Public Offering of Common Stock
Patient Daily
| May 18, 2023
Zynex Announces Update Regarding Previously Announced Offerings
Patient Daily
| May 18, 2023
Zynex Prices Upsized $52.5 Million Convertible Senior Notes Offering
Patient Daily
| Apr 24, 2023
Zynex, Inc. to Announce First Quarter 2023 Financial Results
Trending
Patient Daily
| Jul 15, 2025
Scottsdale Sinus & Allergy Center garners 500+ Google reviews with a 4.9-star rating
Patient Daily
| Jul 11, 2025
Physician assistant on headaches and sinusitis: ‘Sinus headaches are known to trigger your migraines’
Patient Daily
| Jul 15, 2025
Gulf Coast Breathe Free Sinus & Allergy Centers earns 250+ Google reviews with a 4.9-star rating
+
Pharmaceuticals
Patient Daily
| Jul 10, 2025
PhRMA Executive VP: ‘State policymakers can lead the way and must address 340B abuse and protect patients from PBMs'